Reliance Life Sciences is the pioneer
in embryonic stem cell research in India
and is involved in developing cell therapies
to address neural, cardiac and metabolic
disorders. Research focus is on basic
aspects such as gene discovery, drug discovery
and establishment of several fully characterized
stem cell lines. Given the huge disease
burden and the need for affordable diagnostics
and therapies in India, the group aims
to come up with better and cost-effective
ways to treat people or even treat previously
untreated conditions.
Recognised by the National Institutes
of Health, USA, Reliance Life Sciences
fully complies with the criteria for derivation
of human embryonic stem cells of NIH (USA)
and ICMR (India).
Areas of Research
- Derivation, characterization and
maintenance of human embryonic stem cell
lines
- Differentiation of human embryonic
stem cells into neural, cardiac, pancreatic
and hepatic lineages
- Development of cell based therapies
for metabolic disorders, neuro-degeneration
and cardiac disorders
- Development of cells of various
types derived from embryonic stem cells
for efficacy and toxicology studies
- Understanding of stem cell biology
at a basic level
Workshop
A five-day hands on workshop on basics
of human embryonic stem cell culture techniques
is organised every year during January-February.
This workshop is for researchers who are
interested in hESC and provides training
on hESC passaging, maintenance and characterisation.
Cell Lines for Research
Embryonic stem cell lines from Reliance
Life Sciences are available for research
purposes from the National Centre for
Cell Science (NCCS), Pune, India. Please
email Director, NCCS at gcmishra@nccs.res.in
